News
ISOLOGIC makes $29,9 million investment in advanced isotope production facility in Quebec
Montreal, June 4, 2024 – ISOLOGIC Innovative Radiopharmaceuticals is investing $29,9 million to support the growth of the radiopharmaceutical industry and to reinforce its critical role in the field of nuclear medicine and the Canadian medical isotope...
ISOLOGIC Launches Illuccix™ PSMA PET Imaging Agent to Detect Prostate Cancer
Montreal, March 16th, 2023 – Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix™, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada. 24,000 men are diagnosed...
First diagnostic radiotracer for early diagnosis of Alzheimer’s disease approved in Canada
PIRAMAL IMAGING SA AND ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ANNOUNCE COMMERCIAL APPROVAL OF NEURACEQ™ BY HEALTH CANADA Montreal, February 28, 2017 /CNW Telbec - Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce that...
Telix and Isologic sign License and Distribution Agreement for Illuccix™ for Canada
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a license and distribution agreement with Isologic Innovative Pharmaceuticals Ltd (Isologic) for the commercialisation of Telix’s investigational prostate cancer...
Isologic Innovatives Pharmaceuticals Seminar – SNMMI Annual Conference – June 2022
Our scientific event organized on June 13, 2022 during the SNMMI Annual Conference was a great success, We thank all the experts who accepted our invitation and took part in this seminar dedicated to PET imaging agents. Two international experts offered...
CPDC, New acquisition
Dear customers, We are pleased to announce that Isologic has just completed the acquisition of the FDG Canadian distribution business from Centre for Probe Development and Commercialization (CPDC). As a result, all FDG customers serviced by CPDC are,...
Facility Disclosure
Facility Disclosure
NEW PRODUCT AVAILABLE
January 9th, 2020 Dear Valued Customer, It is with great pleasure that we would like to inform you that Isologic has a new product within its portfolio. We are introducing Antimony Sulfide Colloid Tc99m injection. This product is indicated for use as an...
Gallium-68 generator, Galli Eo®
IRE Elit and Isologic announce the approval of the Gallium-68 generator, Galli Eo®, as a drug in Canada December 5th, 2019 - Fleurus, Belgium & Montreal, Canada: IRE ELIT, Belgian radiopharmaceutical company, has just received the Notice of...